Civic Intelligence

Alternatives Research and Development Fo

EIN 23-2740843 • 501(c)3 • Jenkintown, PA

Profile

The mission of the ardf is to fund and promote the development, validation and adoption of non-animal methods in biomedical research, product testing, and education.

801 Old York Road 218Jenkintown, PA 19046

www.ardf-online.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

10th percentile

0.00x

Higher debt load relative to assets than 10% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Source year 2024

Liabilities / Revenue

13th percentile

0.02x

Higher debt load relative to revenue than 13% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Source year 2024

Net Margin

92nd percentile

61%

Higher net margin than 92% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Source year 2024

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

79th percentile

19%

Faster asset growth than 79% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Annualized from 2023 to 2024

Revenue Growth

96th percentile

184%

Faster revenue growth than 96% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Annualized from 2023 to 2024

Assets

Up

$16,848,676

Up $2,643,730 (+19%) from 2023

Liabilities

Up

$44,137

Up $27,959 (+173%) from 2023

Net Assets

Up

$16,804,539

Up $2,615,771 (+18%) from 2023

Revenue

Up

$2,129,417

Up $1,378,549 (+184%) from 2023

Expenses

Up

$834,489

Up $200,064 (+32%) from 2023

Net Income

Up

$1,294,928

Up $1,178,485 (+1012%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$20M$15M$10M$5.0M$0Assets 2011: $7,080,739Liabilities 2011: $4,969Net Assets 2011: $7,075,7702011Assets 2012: $7,532,572Liabilities 2012: $1,250Net Assets 2012: $7,531,3222012Assets 2013: $8,650,525Liabilities 2013: $10,135Net Assets 2013: $8,640,3902013Assets 2014: $8,777,755Liabilities 2014: $2,567Net Assets 2014: $8,775,1882014Assets 2015: $8,826,992Liabilities 2015: $2,409Net Assets 2015: $8,824,5832015Assets 2016: $9,509,758Liabilities 2016: $16,108Net Assets 2016: $9,493,6502016Assets 2017: $10,656,228Liabilities 2017: $43,374Net Assets 2017: $10,612,8542017Assets 2018: $10,007,851Liabilities 2018: $1,335Net Assets 2018: $10,006,5162018Assets 2019: $11,841,958Liabilities 2019: $6,774Net Assets 2019: $11,835,1842019Assets 2020: $13,902,918Liabilities 2020: $45,380Net Assets 2020: $13,857,5382020Assets 2021: $15,528,574Liabilities 2021: $45,018Net Assets 2021: $15,483,5562021Assets 2022: $11,875,792Liabilities 2022: $42,464Net Assets 2022: $11,833,3282022Assets 2023: $14,204,946Liabilities 2023: $16,178Net Assets 2023: $14,188,7682023Assets 2024: $16,848,676Liabilities 2024: $44,137Net Assets 2024: $16,804,5392024

Highlighted filing

2024

Assets$16,848,676
Liabilities$44,137
Net Assets$16,804,539

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$3.0M$2.0M$1.0M$0Expenses 2011: $287,1732011Expenses 2012: $382,1632012Revenue 2013: $598,480Expenses 2013: $411,723Net Income 2013: $186,7572013Revenue 2014: $696,665Expenses 2014: $450,219Net Income 2014: $246,4462014Revenue 2015: $655,933Expenses 2015: $463,403Net Income 2015: $192,5302015Revenue 2016: $769,056Expenses 2016: $492,308Net Income 2016: $276,7482016Revenue 2017: $644,696Expenses 2017: $531,390Net Income 2017: $113,3062017Revenue 2018: $963,182Expenses 2018: $567,589Net Income 2018: $395,5932018Revenue 2019: $945,776Expenses 2019: $525,410Net Income 2019: $420,3662019Revenue 2020: $944,011Expenses 2020: $527,042Net Income 2020: $416,9692020Revenue 2021: $1,584,193Expenses 2021: $540,377Net Income 2021: $1,043,8162021Revenue 2022: $859,795Expenses 2022: $581,268Net Income 2022: $278,5272022Revenue 2023: $750,868Expenses 2023: $634,425Net Income 2023: $116,4432023Revenue 2024: $2,129,417Expenses 2024: $834,489Net Income 2024: $1,294,9282024

Highlighted filing

2024

Revenue$2,129,417
Expenses$834,489
Net Income$1,294,928

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$16.8$0.04$16.8$2.13$0.83$1.29
2023Detailed filing. Detailed filing data is available for this year.$14.2$0.02$14.2$0.75$0.63$0.12
2022Detailed filing. Detailed filing data is available for this year.$11.9$0.04$11.8$0.86$0.58$0.28
2021Detailed filing. Detailed filing data is available for this year.$15.5$0.05$15.5$1.58$0.54$1.04
2020Detailed filing. Detailed filing data is available for this year.$13.9$0.05$13.9$0.94$0.53$0.42
2019Detailed filing. Detailed filing data is available for this year.$11.8$0.01$11.8$0.95$0.53$0.42
2018Detailed filing. Detailed filing data is available for this year.$10.0$0.00$10.0$0.96$0.57$0.40
2017Detailed filing. Detailed filing data is available for this year.$10.7$0.04$10.6$0.64$0.53$0.11
2016Detailed filing. Detailed filing data is available for this year.$9.51$0.02$9.49$0.77$0.49$0.28
2015Detailed filing. Detailed filing data is available for this year.$8.83$0.00$8.82$0.66$0.46$0.19
2014Detailed filing. Detailed filing data is available for this year.$8.78$0.00$8.78$0.70$0.45$0.25
2013Detailed filing. Detailed filing data is available for this year.$8.65$0.01$8.64$0.60$0.41$0.19
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$7.53$0.00$7.53$0.38
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$7.08$0.00$7.08$0.29
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Apr 23, 2025
Return Version
2024v5.1
Gross Receipts
$4,547,866
Mission and Program Overview

Mission

The mission of the ardf is to fund and promote the development, validation and adoption of non-animal methods in biomedical research, product testing, and education.

Ardf promotes and develops alternative scientific solutions to the problem of animal testing.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$12,634,377$14,050,290▲ $1,415,913
Savings and Temporary Cash Investments$1,044,307$2,260,339▲ $1,216,032
Cash and Non-Interest-Bearing Accounts$80,052$46,218▼ $33,834
Accounts Receivable$18,075$18,069▼ $6
Prepaid Expenses and Deferred Charges$3,358$3,250▼ $108
Land, Buildings, and Equipment, Net$1,500$900▼ $600
Total Assets$14,204,946$16,848,676▲ $2,643,730
Other Assets Total$423,277$469,610▲ $46,333
Liabilities
Other Liabilities$8,682$40,460▲ $31,778
Accounts Payable and Accrued Expenses$7,496$3,677▼ $3,819
Total Liabilities$16,178$44,137▲ $27,959
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$13,229,485$14,624,283▲ $1,394,798
Net Assets With Donor Restrictions$959,283$2,180,256▲ $1,220,973
Total Net Assets Fund Balance$14,188,768$16,804,539▲ $2,615,771
Total Liabilities and Net Assets / Fund Balance$14,204,946$16,848,676▲ $2,643,730

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$900$11,496$12,396

Endowment Activity

PeriodBeginningContrib.Gain/LossOther UsesEnd
2024$12,634,377-▲ $1,975,913$560,000$14,050,290
2023$10,366,590-▲ $2,667,787$400,000$12,634,377
2022$14,214,680-▼ $3,448,036$400,054$10,366,590
2021$12,674,289-▲ $1,890,391$350,000$14,214,680
2020$10,737,802-▲ $2,311,583$375,096$12,674,289
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Luke KleinBoard Member--$105,701$105,701
Sue a LearyPresidentPT$20,000$74,790$94,790

Board Members and Trustees

NameTitle
Joseph LudwigVice President
Francis Krafchik Deceased in 2024Board Member
Nadia S AdawiBoard Member
Robert FinnBoard Member
Denise CowieSecretary
Aaron McintyreTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Morgan StanleyInvestment Services1585 BROADWAY, New York, NY 10036$142,930
Revenue and Support

Revenue Composition

Contributions and Grants
$1,233,029
Program Service Revenue
$0
Investment Income
$896,388
Other Revenue
$0
All Other Contributions
$1,233,029
Change in Net Assets
$1,294,928

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,129,417
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$1,177,913
Total Revenue per Audited Statements
$3,307,330
Total Revenue per Form 990
$2,129,417
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$413,605
Other Expenses$366,181
Salaries, Compensation, and Employee Benefits$54,703
Total Fundraising Expense$3,879
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$314,914--$314,914
Fees for Services Other$149,651$132$34$149,817
Fees for Service Investment Mgmnt Fees-$142,930-$142,930
Foreign Grants$88,691--$88,691
Current Officers, Directors, Trustees, and Key Employees$20,000--$20,000
Other Salaries and Wages$7,279$10,055$2,588$19,922
Occupancy$18,338$633-$18,971
Conferences and Meetings$18,919--$18,919
Fees for Services Accounting-$18,725-$18,725
Other Employee Benefits$7,291$3,255$1,000$11,546
Grants to Domestic Individuals$10,000--$10,000
Office Expenses$9,098$394$16$9,508
Fees for Services Legal-$4,930-$4,930
Payroll Taxes$2,092$902$241$3,235
Depreciation Depletion$600--$600
Other Expenses$43$43-$86
Insurance$61$20-$81
Total Functional Expenses$648,559$182,051$3,879$834,489

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Form 990$834,489
Expenses per Audited Statements$691,559
Total Expenses per Audited Statements$691,559
Expenses Not Reported on Financial Statements$142,930
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Beth Israel Deaconess Medical CenterBoston, MA501(c)(3)Dr. Ramaswamy Krishnan Research Grant a Human Precision-cut Lung Slice-based Platform for Fibrotic Drug Discovery$40,000
Duke University School of MedicineDurham, NC501(c)(3)Dr. Wonjae Lee Research Grant Developing Human Cell-based Glioblastoma Models Free From Animal Derivatives$40,000
Michigan State UniversityEast Lansing, MI501(c)(3)Dr. Aitor Aguirre Research Grant New Human Models for the Study of Atrial Fibrillation$40,000
University of Massachusetts Chan Medical SchoolWorcester, MA501(c)(3)Dr. Tien-chan Hsieh Research Grant Computational Discovery of Long Non-coding Rnas as Novel Relapse Risk Biomarkers for Pediatric Acute Lymphoblastic Leukemia$40,000
University of WashingtonSeattle, WA501(c)(3)Dr. Laura Crisa Research Grant Modeling Human Bone Marrow Engraftment and Hematopoiesis in a Micro-fluidic Platform$40,000
University of Wisconsin-madisonMadison, WI501(c)(3)Dr. Matthew Brown Research Grant in Vitro Transplantation Modeling Using Induced Pluripotent Stem Cell-derived Grafts$40,000
Rush University Medical CenterChicago, IL501(c)(3)Dr. Rachel Miller Research Grant Modeling Joint Pain Using an Animal-free System on a Chip$39,996
University of Northern IowaCedar Falls, IA501(c)(3)Dr. Nilda Rodriguez Research Grant - Developing a Model to Study Lipid Bodies and Sex-dependent Immune Responses in Human Monocyte-derived Macrophages$17,915
American Society for Cellular and Computational ToxicologyGaithersburg, MD501(c)(3)Sponsorhip of Ascct Meeting Event$5,697

International Summary

Offices
0
Employees
1
Spending
$220,301

International Compliance

Foreign grant records maintained
No
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland)Program ServicesGrant Program Management01$131,610
Europe (including Iceland & Greenland)Program ServicesResearch Grants00$88,691
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Lease Obligations$40,258
Payable to Affiliate$202
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

The president, treasurer and board of directors review the form 990 before it is filed.

Form 990, Part VI, Section B, Line 12C

The organization follows the policies of its affiliate, american anti-vivisection society (aavs), with which it shares its board of directors. The board of directors monitors and enforces compliance with the conflict of interest policies (as determined by aavs). Annual disclosure forms are collected from each board member and reviewed by the president who ensures that members recuse themselves from voting on any matters in which they may have a dual interest. The board of directors, excluding the president, ensures that the president recuses herself in case of a potential conflict of interest. The conflict of interest policy explicitly deems family and business relationships to have potential for conflicts and requests detailed information on any such relationships as part of the annual conflict of interest policy process.

Form 990, Part VI, Section B, Line 15A

The organization's compensation policies are dictated by its affiliate, american anti-vivisection society (aavs) with whom it shares a board of directors. The board of directors determines compensation of the president by comparing with compensation of equivalent positions using publicly available data. Note the president's salary is determined by aavs but is reported on both returns. Decisions are recorded in board minutes and materials.

Form 990, Part VI, Section C, Line 19

Governing documents, the conflict of interest policy, and financial statements are available upon request.

Filing and Contact Details

Filer

Filer Name
Alternatives Research and Development Fo
EIN
23-2740843
Phone
2158878076
Address
801 OLD YORK ROAD 218, JENKINTOWN, PA 19046

Signing Officer

Name
Sue a Leary
Title
President
Phone
2158878076
Signed
2025-04-23
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Sue a Leary
Formed
1993
Legal Domicile
Pa
Voting Board Members
8
Independent Board Members
6
Employees
1
Volunteers
10

Preparer

Firm
Dunlapslk Pc
Address
1300 HORIZON DRIVE SUITE 106, CHALFONT, PA 18914
Preparer
Julia L Davis
Phone
2675943755
Supplemental Narrative

Additional Explanations

Form 990, Part V, Line 24 and Part IX

Salaries reflected on the statement of functional expenses include allocations of salaries as a portion of management expenses that the organization pays to its affilate, the american anti-vivisection society. Note that the one employee, sue leary, is paid by a common paymaster. The organization's affiliate american anti-vivisection society. There is no w-3 reported for this entity; all filing requirements are met through the affiliate as mentioned.

Form 990, Part IX, Line 11G

Contract labor: program service expenses 149,473. Management and general expenses 0. Fundraising expenses 0. Total expenses 149,473. Other professional fees: program service expenses 178. Management and general expenses 132. Fundraising expenses 34. Total expenses 344.

FORM 990, PART XI, LINE 9:

Unrealized loss on beneficial interest in perpetual trust 14,757.

FORM 990, PART XII, LINE 2C:

There was no change in the audit oversight process from the prior year.

Financial Statement Notes

PART V, LINE 4:

The organization's quasi-endowment funds fund the various activities of ardf. This includes funding research projects that develop non-animal alternatives to traditional animal experiments and sponsorship of scientific meetings promoting alternatives.

PART X, LINE 2:

Management believes that it has appropriate support for any tax provisions taken, and as such, the foundation does not have any uncertian tax positions that are material to the financial statements.

PART XI, LINE 2D - OTHER ADJUSTMENTS:

Unrealized gain on beneficial interest in perpetual trust 14,757. Investment fees -142,930.

Raw XML AppendixShowing 400 of 693 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt07496
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt03677
IRS990/AccountsReceivableGrp/BOYAmt018075
IRS990/AccountsReceivableGrp/EOYAmt018069
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0ARDF PROMOTES AND DEVELOPS ALTERNATIVE SCIENTIFIC SOLUTIONS TO THE PROBLEM OF ANIMAL TESTING.
IRS990/AllOtherContributionsAmt01233029
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum02158878076
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0801 OLD YORK ROAD SUITE 218
IRS990/BooksInCareOfDetail/USAddress/CityNm0JENKINTOWN
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019046
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt080052
IRS990/CashNonInterestBearingGrp/EOYAmt046218
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt020000
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt020000
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt018919
IRS990/ConferencesMeetingsGrp/TotalAmt018919
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt0142930
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt01585 BROADWAY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0NEW YORK
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0NY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd010036
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0MORGAN STANLEY
IRS990/ContractorCompensationGrp/ServicesDesc0INVESTMENT SERVICES
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01233029
IRS990/CYGrantsAndSimilarPaidAmt0413605
IRS990/CYInvestmentIncomeAmt0896388
IRS990/CYOtherExpensesAmt0366181
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt01294928
IRS990/CYSalariesCompEmpBnftPaidAmt054703
IRS990/CYTotalExpensesAmt0834489
IRS990/CYTotalFundraisingExpenseAmt03879
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02129417
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ProgramServicesAmt0600
IRS990/DepreciationDepletionGrp/TotalAmt0600
IRS990/Desc0THE "ANNUAL OPEN" GRANT PROGRAM FUNDS INNOVATIVE ALTERNATIVE METHODS TO REDUCE OR REPLACE ANIMAL USE IN RESEARCH AND TESTING.IN 2024, ARDF FUNDED THE FOLLOWING PROJECTS FOR SCIENTIFIC RESEARCH: 1) NEW HUMAN MODELS FOR THE STUDY OF ATRIAL FIBRILLATION; 2) IN VITRO TRANSPLANTATION MODELING USING INDUCED PLURIPOTENT STEM CELL-DERIVED GRAFTS; 3) MODELING HUMAN BONE MARROW ENGRAFTMENT AND HEMATOPOIESIS IN A MICRO-FLUIDIC PLATFORM; 4) A HUMAN BLADDER MODEL TO DECIPHER HOST-UROPATHOGEN INTERACTIONS FROM TISSUE TO SINGLE-CELLS; 5) COMPUTATIONAL DISCOVERY OF LONG NON-CODING RNAS AS NOVEL RELAPSE RISK BIOMARKERS FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA; 6) A HUMAN PRECISION-CUT LUNG SLICE-BASED PLATFORM FOR FIBROTIC DRUG DISCOVERY; 7) DEVELOPING HUMAN CELL-BASED GLIOBLASTOMA MODELS FREE FROM ANIMAL DERIVATIVES; 8) MODELING JOINT PAIN USING AN ANIMAL-FREE SYSTEM ON A CHIP; 9) DEVELOPING A MODEL TO STUDY LIPID BODIES AND SEX-DEPENDENT IMMUNE RESPONSES IN HUMAN MONOCYTE-DERIVED MACROPHAGES; 10) REGULATORY T CELL SUPPRESSIVE FUNCTIONS IN MIGRAINE.THIS YEAR'S FOCUS ON DEVELOPING MODELS TO AID DEVELOPMENT OF TREATMENTS UNDERSCORES THE TREMENDOUS POTENTIAL OF IN VITRO MODELS FOR BIOMEDICAL RESEARCH. BY SUPPORTING RESEARCH TO DEVELOP ALTERNATIVE, ANIMAL-FREE MODELS, ARDF CONTINUES TO ADVANCE BOTH ANIMAL WELFARE AND HUMAN HEALTH.ARDF ALSO ADDED ITS EXPERTISE TO POLICY DISCUSSIONS OF ADVANCING ALTERNATIVE METHODS. FOR EXAMPLE, IN 2024, ARDF PRESIDENT SUE LEARY SERVED ON THE SCIENTIFIC ADVISORY COMMITTEE ON ALTERNATIVE TOXICOLOGICAL METHODS TO A DEPARTMENT OF THE NATIONAL INSTITUTES OF HEALTH. ARDF AWARDED THE WILLIAM AND ELEANOR CAVE AWARD TO ANNA LOWIT, PHD, FOR HER CAREER ACCOMPLISHMENTS IN IMPLEMENTING ALTERNATIVE APPROACHES IN CHEMICAL AND PESTICIDE TESTING. ARDF SPONSORED SCIENTIFIC MEETINGS, AND EDUCATION AND OUTREACH ON ALTERNATIVE METHODS TO ACCELERATE UNDERSTANDING AND COLLABORATION.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0959283
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt02180256
IRS990/DonorRstrOrQuasiEndowmentsInd01
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt01
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0648559
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt018725
IRS990/FeesForServicesAccountingGrp/TotalAmt018725
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt04930
IRS990/FeesForServicesLegalGrp/TotalAmt04930
IRS990/FeesForServicesOtherGrp/FundraisingAmt034
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0132
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0149651
IRS990/FeesForServicesOtherGrp/TotalAmt0149817
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt0142930
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0142930
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt088691
IRS990/ForeignGrantsGrp/TotalAmt088691
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt035.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt135.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt30.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt40.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt012.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt10.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt20.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt06530
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt113486
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/PersonNm0SUE A LEARY
IRS990/Form990PartVIISectionAGrp/PersonNm1LUKE KLEIN
IRS990/Form990PartVIISectionAGrp/PersonNm2NADIA S ADAWI
IRS990/Form990PartVIISectionAGrp/PersonNm3ROBERT FINN
IRS990/Form990PartVIISectionAGrp/PersonNm4FRANCIS KRAFCHIK DECEASED IN 2024
IRS990/Form990PartVIISectionAGrp/PersonNm5JOSEPH LUDWIG
IRS990/Form990PartVIISectionAGrp/PersonNm6AARON MCINTYRE
IRS990/Form990PartVIISectionAGrp/PersonNm7DENISE COWIE
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt020000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt068260
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt192215
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt2BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5VICE PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt6TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt7SECRETARY
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01993
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolAndSepBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0655199
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt08
IRS990/GrantAmt0413605
IRS990/GrantsToDomesticIndividualsGrp/ProgramServicesAmt010000
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt010000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0314914
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0314914
IRS990/GrantsToIndividualsInd01
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt03073648
IRS990/GrossReceiptsAmt04547866
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt06
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartVInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt020
IRS990/InsuranceGrp/ProgramServicesAmt061
IRS990/InsuranceGrp/TotalAmt081
IRS990/InvestmentIncomeGrp/ExclusionAmt0241189
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0241189
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt012634377
IRS990/InvestmentsPubTradedSecGrp/EOYAmt014050290
IRS990/IRPDocumentCnt01
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt011496
IRS990/LandBldgEquipBasisNetGrp/BOYAmt01500
IRS990/LandBldgEquipBasisNetGrp/EOYAmt0900
IRS990/LandBldgEquipCostOrOtherBssAmt012396
IRS990/LegalDomicileStateCd0PA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt02418449
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF THE ARDF IS TO FUND AND PROMOTE THE DEVELOPMENT, VALIDATION AND ADOPTION OF NON-ANIMAL METHODS IN BIOMEDICAL RESEARCH, PRODUCT TESTING, AND EDUCATION.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt014188768
IRS990/NetAssetsOrFundBalancesEOYAmt016804539
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0655199
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0655199
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt01306086
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt013229485
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt014624283
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0633
IRS990/OccupancyGrp/ProgramServicesAmt018338
IRS990/OccupancyGrp/TotalAmt018971
IRS990/OfficeExpensesGrp/FundraisingAmt016
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0394
IRS990/OfficeExpensesGrp/ProgramServicesAmt09098
IRS990/OfficeExpensesGrp/TotalAmt09508
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0423277
IRS990/OtherAssetsTotalGrp/EOYAmt0469610
IRS990/OtherChangesInNetAssetsAmt014757
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt01000
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt03255
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt07291
IRS990/OtherEmployeeBenefitsGrp/TotalAmt011546
IRS990/OtherExpensesGrp/Desc0RESEARCH AND INFORMATIO
IRS990/OtherExpensesGrp/Desc1POSTAGE AND SHIPPING
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt032
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt143
IRS990/OtherExpensesGrp/ProgramServicesAmt01582
IRS990/OtherExpensesGrp/ProgramServicesAmt143
IRS990/OtherExpensesGrp/TotalAmt01614
IRS990/OtherExpensesGrp/TotalAmt186
IRS990/OtherLiabilitiesGrp/BOYAmt08682
IRS990/OtherLiabilitiesGrp/EOYAmt040460
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt02588
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt010055
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt07279
IRS990/OtherSalariesAndWagesGrp/TotalAmt019922
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt0241
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0902
IRS990/PayrollTaxesGrp/ProgramServicesAmt02092
IRS990/PayrollTaxesGrp/TotalAmt03235
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt03358
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt03250
IRS990/PrincipalOfficerNm0SUE A LEARY
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt077619
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0266937
IRS990/PYInvestmentIncomeAmt0673249
IRS990/PYOtherExpensesAmt0320027
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0116443
IRS990/PYSalariesCompEmpBnftPaidAmt047461
IRS990/PYTotalExpensesAmt0634425
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0750868
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt01294928
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt01044307
IRS990/SavingsAndTempCashInvstGrp/EOYAmt02260339
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01233029
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt077619
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0333654
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt069409
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt074498
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt01788209
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0241189
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0185725
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0140054
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0154090
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0141897
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0862955
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus3YearsAmt08505
IRS990ScheduleA/OtherIncome170Grp/TotalAmt08505
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.67230
IRS990ScheduleA/PublicSupportPY170Pct00.46110
IRS990ScheduleA/PublicSupportTotal170Amt01788209
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01233029
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt077619
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0333654
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt069409
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt074498
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt01788209
IRS990ScheduleA/TotalSupportAmt02659669
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/AvgGrassrootsLobbyingExpendGrp/CurrentYearMinus1Amt015342
IRS990ScheduleC/AvgGrassrootsLobbyingExpendGrp/CurrentYearMinus2Amt015679
IRS990ScheduleC/AvgGrassrootsLobbyingExpendGrp/TotalAmt031021
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/CurrentYearMinus1Amt082655
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/CurrentYearMinus2Amt073472
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/CurrentYearMinus3Amt026514
IRS990ScheduleC/AvgGrassrootsNontaxableGrp/TotalAmt0182641
IRS990ScheduleC/AvgLobbyingNontaxableAmountGrp/CurrentYearMinus1Amt0330620
IRS990ScheduleC/AvgLobbyingNontaxableAmountGrp/CurrentYearMinus2Amt0293887
IRS990ScheduleC/AvgLobbyingNontaxableAmountGrp/CurrentYearMinus3Amt0106057
IRS990ScheduleC/AvgLobbyingNontaxableAmountGrp/TotalAmt0730564
IRS990ScheduleC/AvgTotalLobbyingExpendGrp/CurrentYearMinus1Amt021761
IRS990ScheduleC/AvgTotalLobbyingExpendGrp/CurrentYearMinus2Amt022629
IRS990ScheduleC/AvgTotalLobbyingExpendGrp/CurrentYearMinus3Amt090
IRS990ScheduleC/AvgTotalLobbyingExpendGrp/TotalAmt044480
IRS990ScheduleC/GrassrootsCeilingAmt0273962
IRS990ScheduleC/LobbyingCeilingAmt01095846
IRS990ScheduleD/BoardDesignatedBalanceEOYPct01.00000
IRS990ScheduleD/CYEndwmtFundGrp/BeginningYearBalanceAmt012634377
IRS990ScheduleD/CYEndwmtFundGrp/EndYearBalanceAmt014050290
IRS990ScheduleD/CYEndwmtFundGrp/InvestmentEarningsOrLossesAmt01975913
IRS990ScheduleD/CYEndwmtFundGrp/OtherExpendituresAmt0560000
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/BeginningYearBalanceAmt010366590
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/EndYearBalanceAmt012634377
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt02667787
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/OtherExpendituresAmt0400000
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/BeginningYearBalanceAmt014214680
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/EndYearBalanceAmt010366590
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt0-3448036
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/OtherExpendituresAmt0400054
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/BeginningYearBalanceAmt012674289
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/EndYearBalanceAmt014214680
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt01890391
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/OtherExpendituresAmt0350000
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/BeginningYearBalanceAmt010737802
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/EndYearBalanceAmt012674289
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt02311583
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/OtherExpendituresAmt0375096
IRS990ScheduleD/EndowmentsHeldRelatedOrgInd00
IRS990ScheduleD/EndowmentsHeldUnrelatedOrgInd00
IRS990ScheduleD/EquipmentGrp/BookValueAmt0900
IRS990ScheduleD/EquipmentGrp/DepreciationAmt011496
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt012396
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt0142930
IRS990ScheduleD/ExpensesSubtotalAmt0691559
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt0142930
IRS990ScheduleD/NetUnrealizedGainsInvstAmt01306086
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt040258
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt1202
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0LEASE OBLIGATIONS
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1PAYABLE TO AFFILIATE
IRS990ScheduleD/OtherRevenueAmt0-128173
IRS990ScheduleD/PrmnntEndowmentBalanceEOYPct00.00000
IRS990ScheduleD/RevenueNotReportedAmt01177913
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt00
IRS990ScheduleD/RevenueSubtotalAmt02129417
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE ORGANIZATION'S QUASI-ENDOWMENT FUNDS FUND THE VARIOUS ACTIVITIES OF ARDF. THIS INCLUDES FUNDING RESEARCH PROJECTS THAT DEVELOP NON-ANIMAL ALTERNATIVES TO TRADITIONAL ANIMAL EXPERIMENTS AND SPONSORSHIP OF SCIENTIFIC MEETINGS PROMOTING ALTERNATIVES.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1MANAGEMENT BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX PROVISIONS TAKEN, AND AS SUCH, THE FOUNDATION DOES NOT HAVE ANY UNCERTIAN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt2UNREALIZED GAIN ON BENEFICIAL INTEREST IN PERPETUAL TRUST 14,757. INVESTMENT FEES -142,930.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART V, LINE 4:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc1PART X, LINE 2:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc2PART XI, LINE 2D - OTHER ADJUSTMENTS:
IRS990ScheduleD/TermEndowmentBalanceEOYPct00.00000
IRS990ScheduleD/TotalBookValueLandBuildingsAmt0900
IRS990ScheduleD/TotalExpensesPerForm990Amt0834489

Document Assets

No mirrored PDF or thumbnail assets are attached yet.